Stebbing Justin, Patterson Steve, Gotch Frances
Department of Immunology, Division of Investigative Science, Faculty of Medicine, Imperial College of Science, Technology and Medicine, The Chelsea and Westminster Hospital, 369 Fulham Road, London SWIO 9NH, United Kingdom.
Cell Res. 2003 Feb;13(1):1-7. doi: 10.1038/sj.cr.7290145.
Fewer than one million HIV infected individuals are currently receiving anti-retroviral therapy. The limitations of such treatment have underscored the need to develop more effective strategies to control the spread and pathogenesis of HIV. Typically, naturally occurring protective immune responses provide the for such development. It is now clear however that HIV can utilise the milieu of an activated immune system to its own replicative advantage. Mobilisation of the immune response, intended to thwart the virus, may instead fuel its dissemination, 'immune escape' and spread. The immense genetic variation of HIV contributes to lack of immune control and the development of progressive disease in the majority of infected, untreated individuals. Further delineation of the intimate interactions between the HIV and the immune system will be critical and recent advances in this direction are discussed.
目前接受抗逆转录病毒治疗的HIV感染者不到100万。这种治疗方法的局限性凸显了开发更有效策略来控制HIV传播和发病机制的必要性。通常,自然产生的保护性免疫反应为这种发展提供了依据。然而,现在很清楚的是,HIV能够利用激活的免疫系统环境来实现自身的复制优势。旨在对抗病毒的免疫反应动员反而可能助长其传播、“免疫逃逸”和扩散。HIV的巨大基因变异导致大多数未接受治疗的感染者缺乏免疫控制并发展为进行性疾病。进一步阐明HIV与免疫系统之间的密切相互作用至关重要,本文将讨论这方面的最新进展。